Citation Impact

Citing Papers

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
A systematic review and meta-analysis on the therapeutic equivalence of statins
2009
Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study
2015
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Characterization of lacrimal gland lesions and possible pathogenic mechanisms of keratoconjunctivitis sicca in dogs with leishmaniosis
2005
TFOS DEWS II Management and Therapy Report
2017 Standout
Clinical Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops
2012
Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits
2015
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis
2012
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Beneficial Vascular and Metabolic Effects of Peroxisome Proliferator-Activated Receptor-α Activators
2005
V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose
2013 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout

Works of Cengiz Ceylan being referenced

Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca
2002
The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: A comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia
2005
Rankless by CCL
2026